Literature DB >> 15064332

Phosphorylation and regulation of psychostimulant-sensitive neurotransmitter transporters.

Roxanne A Vaughan1.   

Abstract

The neuronal transporters for the monoamines dopamine, serotonin, and norepinephrine are plasma membrane proteins that serve vital functions in the reuptake and control of synaptic neurotransmitter levels. They are also targets for abused and therapeutic drugs and play pivotal roles in neurological disorders such as depression, schizophrenia, and Parkinson's disease. There is increasing evidence that some activities of these carriers are subject to acute control by treatments that affect phosphorylation pathways, but the molecular basis for this is not understood. Recent work suggests that these regulatory processes may involve phosphorylation of the transporters by protein kinase C and other kinases, and may occur by affecting intrinsic transport activity or by controlling transporter cell surface expression. Phosphorylation-mediated regulation of monoamine transporters provides the potential for acute presynaptic control of neurotransmitter levels during normal neurophysiologic events, and dysregulation of these processes may lead to inappropriate transmitter clearance that contributes to the etiology of neurological disorders.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15064332     DOI: 10.1124/jpet.103.052423

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  20 in total

1.  Dopamine-sensitive signaling mediators modulate psychostimulant-induced ultrasonic vocalization behavior in rats.

Authors:  Stacey N Williams; Ashiwel S Undieh
Journal:  Behav Brain Res       Date:  2015-08-11       Impact factor: 3.332

2.  An N-terminal threonine mutation produces an efflux-favorable, sodium-primed conformation of the human dopamine transporter.

Authors:  Rheaclare Fraser; Yongyue Chen; Bipasha Guptaroy; Kathryn D Luderman; Stephanie L Stokes; Asim Beg; Louis J DeFelice; Margaret E Gnegy
Journal:  Mol Pharmacol       Date:  2014-04-21       Impact factor: 4.436

3.  Phosphorylation of dopamine transporter serine 7 modulates cocaine analog binding.

Authors:  Amy E Moritz; James D Foster; Balachandra K Gorentla; Michelle S Mazei-Robison; Jae-Won Yang; Harald H Sitte; Randy D Blakely; Roxanne A Vaughan
Journal:  J Biol Chem       Date:  2012-11-16       Impact factor: 5.157

4.  Interleukin-1 beta enhances endocytosis of glial glutamate transporters in the spinal dorsal horn through activating protein kinase C.

Authors:  Xisheng Yan; Ruchi Yadav; Mei Gao; Han-Rong Weng
Journal:  Glia       Date:  2014-03-26       Impact factor: 7.452

Review 5.  Monoamine transporters: vulnerable and vital doorkeepers.

Authors:  Zhicheng Lin; Juan J Canales; Thröstur Björgvinsson; Morgane Thomsen; Hong Qu; Qing-Rong Liu; Gonzalo E Torres; S Barak Caine
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

6.  Proline-directed phosphorylation of the dopamine transporter N-terminal domain.

Authors:  Balachandra K Gorentla; Amy E Moritz; James D Foster; Roxanne A Vaughan
Journal:  Biochemistry       Date:  2009-02-10       Impact factor: 3.162

7.  Amphetamine and methamphetamine differentially affect dopamine transporters in vitro and in vivo.

Authors:  J Shawn Goodwin; Gaynor A Larson; Jarod Swant; Namita Sen; Jonathan A Javitch; Nancy R Zahniser; Louis J De Felice; Habibeh Khoshbouei
Journal:  J Biol Chem       Date:  2008-12-01       Impact factor: 5.157

8.  A juxtamembrane mutation in the N terminus of the dopamine transporter induces preference for an inward-facing conformation.

Authors:  Bipasha Guptaroy; Minjia Zhang; Erica Bowton; Francesca Binda; Lei Shi; Harel Weinstein; Aurelio Galli; Jonathan A Javitch; Richard R Neubig; Margaret E Gnegy
Journal:  Mol Pharmacol       Date:  2008-12-19       Impact factor: 4.436

Review 9.  Role of the dopamine transporter in the action of psychostimulants, nicotine, and other drugs of abuse.

Authors:  J Zhu; M E A Reith
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-11       Impact factor: 4.388

10.  Nongenomic mechanisms of physiological estrogen-mediated dopamine efflux.

Authors:  Rebecca A Alyea; Cheryl S Watson
Journal:  BMC Neurosci       Date:  2009-06-16       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.